scholarly journals Hidden intra-mandibular carcinoma cuniculatum appearing in a patient with metastatic prostate cancer: a case report

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Elyette Broly ◽  
Philippe Barthélémy ◽  
Saïd Ciftci ◽  
Christian Borel ◽  
Martin Broly ◽  
...  
2014 ◽  
Vol 8 (5-6) ◽  
pp. 458 ◽  
Author(s):  
Jae Heon Kim ◽  
Byung Wook Yoo ◽  
Won Jae Yang

Cyproterone acetate (CPA) is an anti-androgenic drug that has been used to manage prostate cancer. The drug is well-tolerated, but has hepatotoxic effects. Hepatic failure induced by CPA is rare and urologists tend to overlook its severity. We report a patient with metastatic prostate cancer who developed CPA-induced hepatic failure that manifested as bilirubinuria, which was initially misinterpreted as gross hematuria. The patient died despite receiving critical care. The aim of this study is to sound the alarm about CPA-induced hepatic failure.


2014 ◽  
Vol 20 (2) ◽  
Author(s):  
Gabrielle Brown ◽  
Drew Kurtzman ◽  
Fangru Lian ◽  
James Sligh

2018 ◽  
Vol 21 ◽  
pp. 92-94
Author(s):  
Olamide O. Omidele ◽  
Howard I. Schiff ◽  
William Oh ◽  
Ashutosh Tewari

CHEST Journal ◽  
2014 ◽  
Vol 145 (3) ◽  
pp. 308A
Author(s):  
Abhay Vakil ◽  
Hineshkumar Upadhyay ◽  
Khalid Sherani ◽  
Kelly Cervellione ◽  
Mohammed Babury

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Ahmet Bilici ◽  
Mustafa Dikilitas ◽  
Ozlem Ton Eryilmaz ◽  
Bekir Selim Bagli ◽  
Fatih Selcukbiricik

Prostate cancer commonly metastasizes bones and lymph nodes, but it very rarely spreads to the gastrointestinal tract. However, only five cases of prostate cancer metastatic to the stomach have been previously reported in the literature. We report a case of a 69-year-old man with metastatic prostate cancer who presented with upper gastrointestinal bleeding (UGB) 4 years after the diagnosis. Esophagogastroscopy revealed multiple ulcerations in the gastric body and histopathological examination confirmed gastric metastasis that originated from prostate cancer. Chemotherapy could not be given because of patient's refusal. He was treated with LHRH agonist. We suggest that for a man with prostate cancer diagnosed with UGB, stomach metastasis should be considered in the differential diagnosis of UGB.


Sign in / Sign up

Export Citation Format

Share Document